Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-000810
Filing Date
2025-07-21
Accepted
2025-07-21 11:34:37
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tcrg10q033125.htm   iXBRL 10-Q 416886
2 EXHIBIT 31.1 tcrgex31-1.htm EX-31.1 12455
3 EXHIBIT 31.2 tcrgex31-2.htm EX-31.2 12524
4 EXHIBIT 32.1 tcrgex32-1.htm EX-32.1 8865
  Complete submission text file 0001185185-25-000810.txt   3482188

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tcrg-20250331.xsd EX-101.SCH 33129
6 XBRL CALCULATION FILE tcrg-20250331_cal.xml EX-101.CAL 29061
7 XBRL DEFINITION FILE tcrg-20250331_def.xml EX-101.DEF 171942
8 XBRL LABEL FILE tcrg-20250331_lab.xml EX-101.LAB 262606
9 XBRL PRESENTATION FILE tcrg-20250331_pre.xml EX-101.PRE 186931
57 EXTRACTED XBRL INSTANCE DOCUMENT tcrg10q033125_htm.xml XML 297345
Mailing Address 650 PONCE DE LEON AVE SUITE 300 #2334 ATLANTA GA 30308
Business Address 650 PONCE DE LEON AVE SUITE 300 #2334 ATLANTA GA 30308 404-254-2100
Cannaisseur Group Inc. (Filer) CIK: 0001879270 (see all company filings)

EIN.: 861907561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56664 | Film No.: 251136303
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)